questionText: To ask the Secretary of State for Health and Social Care, whether his department has considered the impact of NICE’s severity modifier, introduced in 2020, on NHS England’s access to innovative cancer medicines which were previously eligible under the end
answerText: The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended ...
heading: Cancer: Drugs